PRESS RELEASE: IVI Research Brief: Open-Source Modeling Builds Trust, Validity, and Rapid-Cycle Learning in Value Assessment
Alexandria, VA — November 23, 2020 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today released its latest Value Blueprints research brief describing the benefits and challenges of employing open-source modeling in value assessment. In open-source models, the […]
PRESS RELEASE: IVI Appoints Dr. Richard Chapman as Chief Science Officer
Alexandria, VA — January 26, 2021 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced that Rick Chapman, PhD, will be its next Chief Science Officer. Chapman, who is currently Director of Health Economics at the Institute […]
Heard at ISPOR: Wide Ranging Podcast with IVI on Advanced Value Assessment Methods and the QALY Controversy
The IVI team sat down with the Journal of Clinical Pathways while at ISPOR for an in-depth discussion about why advanced value assessment is needed and how it’s progressing. The team also discussed the QALY – what it is and whether it can be improved. To listen to the podcast or read the transcript, click […]
IVI Highlighted in Article on Value Assessment in Oncology Treatments
In this month’s Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some of the existing value frameworks in play as well as referencing the work being done by the IVI to employ […]
Open-Source Rx Value Model Designed To Encourage ‘More Productive’ Discussions
Pink Sheet Senior Writer, Cathy Kelly, reports on the goals and objectives of the IVI Open-Source Value Project (OSVP), how the first iteration of the tool on rheumatoid arthritis is intended to serve different health care stakeholders, and what the next application will focus on. Kelly quotes IVI Strategic Advisory Panel Chair, Sam Nussbaum, who […]